These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 12052325)

  • 1. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma.
    Sorkness CA
    Pharmacotherapy; 1997; 17(1 Pt 2):50S-54S. PubMed ID: 9017788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
    Wagener M
    Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
    Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
    Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-leukotrienes: their use in asthma].
    Devillier P; Millart H; Advenier C
    Rev Med Brux; 1997 Sep; 18(4):279-85. PubMed ID: 9411661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of asthma with drugs modifying the leukotriene pathway.
    Drazen JM; Israel E; O'Byrne PM
    N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
    Steinke JW; Culp JA
    Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukotriene antagonists: a new approach in the treatment of asthma].
    Devillier P; Bessard G; Advenier C
    Rev Mal Respir; 1997 Jun; 14(3):159-70. PubMed ID: 9411593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists.
    Schneider I; Bucar F
    Phytother Res; 2005 Apr; 19(4):263-72. PubMed ID: 16041764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
    Hendeles L
    Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukotriene receptor antagonists and bronchial asthma].
    Jäger L; Kroegel C
    Arzneimittelforschung; 1998 Mar; 48(3):205-11. PubMed ID: 9553675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.